Close Menu

This story originally ran on Oct. 20.

By Adam Bonislawski

Somalogic said this week that it has signed a multi-year research agreement with Novartis to use its aptamer-based proteomics platform to aid the pharma firm's drug discovery and development efforts.

The company also announced this week the launch of its new Somaplex Standard product, a panel of 288 assays targeting 287 proteins of interest that it will make available as a research tool for pharma, biotech, and academic clients.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

New US Department of Commerce rules will affect supercomputing in China, according to the Wall Street Journal.

A new analysis finds that it will be more than a century until female computer scientists publish at the same rate as their male counterparts, ScienceInsider reports.

Broad Institute researchers describe an approach they've dubbed "DNA microscopy."

In PLOS this week: epigenetic changes following hepatitis C virus treatment, metagenomic analysis of Ugandan children with febrile illness, and more.